Ticker Details
Natera, Inc. Natera Inc is a provider of diagnostic services predominantly in the United States. It offers various tests which detect chromosomal abnormalities, reasons for miscarriages and paternity.
IPO Date:	July 2, 2015
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$29.58B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.31 | 2.43%
Avg Daily Range (30 D):	$3.62 | 1.62%
Avg Daily Range (90 D):	$3.50 | 1.61%

Institutional Daily Volume
Avg Daily Volume:	.75M
Avg Daily Volume (30 D):	.91M
Avg Daily Volume (90 D):	1.06M

Trade Size
Avg Trade Size (Sh.):	63
Avg Trade Size (Sh.) (30 D):	41
Avg Trade Size (Sh.) (90 D):	42

Institutional Trades
Total Institutional Trades:	7,233
Avg Institutional Trade:	$5.41M
Avg Institutional Trade (30 D):	$13.97M
Avg Institutional Trade (90 D):	$14.52M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$11.09M
Avg Closing Trade (30 D):	$26.26M
Avg Closing Trade (90 D):	$32.18M
Avg Closing Volume:	127.4K

News

Feb 22, 2026 @ 12:30 AM Billionaire Stanley Druckenmiller Is Betting Big o... Source: Lee Samaha

Jan 30, 2026 @ 9:57 AM Esoteric Testing Research Report 2026 - Global $41... Source: Researchandmarkets.Com

Jan 9, 2026 @ 3:53 PM Non-Invasive Prenatal Testing Market is expected t... Source: Verified Market Research

Dec 30, 2025 @ 3:00 PM Reproductive Genetics Market Size to Reach USD 16.... Source: Coherent Market Insights

Dec 11, 2025 @ 6:18 PM Natera New Test Data Could Change How Doctors Mana... Source: Vandana Singh

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-2.29	$-.64	$-.74
Diluted EPS	$-2.29	$-.64	$-.74
Revenue	$2.12B	$592.18M	$546.6M
Gross Profit
Net Income / Loss	$-309.19M	$-87.54M	$-100.94M
Operating Income / Loss	$-351.87M	$-97.58M	$-110.37M
Cost of Revenue
Net Cash Flow	$148.59M	$41.42M	$26.25M
PE Ratio